Yes, at-home STD tests are widely available and can screen for most common sexually transmitted infections, including chlamydia, gonorrhea, syphilis, HIV, trichomoniasis, hepatitis B and C, and herpes. Some give you results at home in about 15 to 20 minutes, while others require you to mail samples to a lab and wait a few days. The technology has advanced quickly in recent years, with the FDA authorizing several new home tests since 2023.
Two Types of At-Home STD Tests
At-home STD testing falls into two categories, and the difference matters for how quickly you get answers.
Rapid-result tests let you collect a sample, run the test, and read results all at home. A rapid HIV test uses an oral swab and delivers results in about 20 minutes. A rapid syphilis test provides results in roughly 15 minutes. The newest addition is the Visby Medical Women’s Sexual Health Test, which screens for chlamydia, gonorrhea, and trichomoniasis using a vaginal swab and a small powered testing device that sends results to a phone app. These are the only STDs that currently have true at-home rapid tests.
Mail-in collection kits cover a broader range of infections. You collect your own samples at home, typically urine, a vaginal or throat swab, or a finger-prick blood spot, then ship everything to a lab in a prepaid mailer. Results come back digitally within a few days to about a week, depending on the lab.
Which STDs You Can Test For
Most major STDs are now testable through at-home kits. Chlamydia and gonorrhea are detected through urine samples or swabs. Syphilis and HIV use blood-based testing, either a finger prick or (for HIV) an oral swab. Trichomoniasis is detected through a vaginal swab. Hepatitis B, hepatitis C, and herpes are screened through blood samples. Multi-infection panels are common with mail-in kits, letting you test for several infections from a single order.
One notable gap: HPV testing still requires a Pap smear, which can’t be done at home. And while herpes blood tests exist, they detect antibodies rather than active infection, so they work best as a screening tool rather than a way to diagnose a current outbreak.
How Accurate Are They?
Self-collected samples are comparable in accuracy to those taken by a clinician. Research published in The BMJ found that self-taken swabs of the throat and rectum produced diagnoses just as accurately as clinician-collected swabs. The method of collection, whether by you or a healthcare provider, did not change the accuracy of results.
The FDA-authorized Visby Medical test offers a concrete example. In clinical validation, it correctly identified 97.2% of positive chlamydia samples, 100% of positive gonorrhea samples, and 97.8% of positive trichomoniasis samples. It also correctly ruled out negative samples more than 98.5% of the time across all three infections. Those numbers are strong enough that the FDA cleared it for over-the-counter use without a prescription.
The main accuracy risk isn’t the test itself but timing. Testing too soon after exposure can produce a false negative because the infection hasn’t built up enough to detect.
When to Test After Exposure
Every STD has a “window period,” the minimum time after exposure before a test can reliably detect it. Testing before this window closes often means a negative result even if you’re infected.
- Chlamydia and gonorrhea: One week catches most cases. Two weeks catches nearly all.
- Trichomoniasis: One week catches most. One month catches nearly all.
- Syphilis: One month catches most. Three months catches nearly all.
- HIV (blood test): Two weeks catches most. Six weeks catches nearly all.
- HIV (oral swab): One month catches most. Three months catches nearly all.
- Herpes: One month catches most. Four months catches nearly all.
- Hepatitis B: Three to six weeks.
- Hepatitis C: Two months catches most. Six months catches nearly all.
If you’re testing because of a specific exposure, the safest approach is to test once after the initial window and again at the longer interval to be thorough. For routine screening without a known exposure, timing is less of a concern.
What They Cost
Pricing varies widely based on the provider, the number of infections tested, and whether you use insurance. Single-infection rapid tests tend to be the least expensive. Comprehensive mail-in panels that screen for multiple STDs at once typically range from around $50 to $200 or more out of pocket. Planned Parenthood, for example, lists a $200 out-of-pocket price for its mail-in kit services, though insurance may reduce that significantly.
Some insurance plans do cover at-home STD testing, and many kits are eligible for purchase with HSA or FSA funds. Coverage depends on your specific plan, so checking with your insurer before ordering is worth the two-minute phone call. Free or low-cost testing programs also exist through local health departments, which can be a better option if cost is a barrier.
What Happens If You Test Positive
A positive result on a rapid at-home test is typically considered preliminary and needs confirmation through follow-up testing with a healthcare provider. This is especially important for HIV, where the CDC recommends follow-up testing after any positive self-test. Many mail-in kit companies connect you with a telehealth provider as part of the service, and some can prescribe treatment directly for bacterial infections like chlamydia and gonorrhea without requiring an in-person visit.
Bacterial STDs (chlamydia, gonorrhea, syphilis, trichomoniasis) are curable with antibiotics. Getting from a positive result to treatment can happen within days if you use a telehealth-integrated service. Viral infections like HIV and hepatitis require longer-term management but benefit enormously from early detection, which is one of the strongest arguments for testing regularly even when you feel fine.
If you need help finding follow-up care, the CDC’s prevention services locator can identify nearby clinics, testing centers, and support services based on your location.
Who Should Consider At-Home Testing
At-home testing is particularly useful if privacy is a priority, if you don’t have easy access to a clinic, or if the idea of an in-person visit has kept you from getting tested at all. It’s also practical for routine screening between annual checkups, especially if you have new or multiple sexual partners.
The CDC recommends that all adults aged 13 to 64 get tested for HIV at least once, and that sexually active women under 25 get annual chlamydia and gonorrhea screening. Anyone with new partners, multiple partners, or inconsistent condom use benefits from more frequent testing. At-home kits make it easier to follow through on that without rearranging your schedule or sitting in a waiting room.